Journals / Turkish Journal of Obstetrics and Gynecology / 2022 / Cilt: 19 - Sayı: 2

COVID-19 related maternal mortality cases in associated with Delta and Omicron waves and the role of lung ultrasound

COVID-19’a bağlı anne ölümü olgularının Delta ve Omikron dalgaları ile ilişkisi ve akciğer ultrasonunun rolü

Pages
88–97
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Of the 1.065 patients, 783 (73.5%) were hospitalized before the Delta wave and the maternal mortality rate was 1.28% (10/783), 243 (22.8%) were hospitalized during the Delta wave and the maternal mortality rate was 7% (17/243) [relative risk (RR)=5.478, 95% confidence interval (CI) (2.54-11.8), z=4.342, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To present coronavirus disease-2019 (COVID-19) related maternal mortality in relation to Delta and Omicron waves and to investigate the role of lung ultrasound (LUS) in estimating mortality.
📊
Key Findings & Data:Materials and Methods: This retrospective cohort study was conducted in the obstetrics and gynecology clinic of a tertiary pandemic hospital between March 2020 and January 2022.
💡
Conclusion & Impact:Of the 1.065 patients, 783 (73.5%) were hospitalized before the Delta wave and the maternal mortality rate was 1.28% (10/783), 243 (22.8%) were hospitalized during the Delta wave and the maternal mortality rate was 7% (17/243) [relative risk (RR)=5.478, 95% confidence interval (CI) (2.54-11.8), z=4.342, p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To present coronavirus disease-2019 (COVID-19) related maternal mortality in relation to Delta and Omicron waves and to investigate the role of lung ultrasound (LUS) in estimating mortality. Materials and Methods: This retrospective cohort study was conducted in the obstetrics and gynecology clinic of a tertiary pandemic hospital between March 2020 and January 2022. The hospitalized pregnant women with COVID-19 diagnosis and maternal deaths were studied in relation with Delta and Omicron waves. The relationship between LUS scores of hospitalized patients and maternal mortality was explored. Results: Thousand and sixty-five pregnant women were hospitalized because of COVID-19 infection. Fifty-one (4.79%) of these patients had critical sickness, 96 (9.01%) of them had severe illness, 62 (5.82%) of them were admitted to the intensive care unit and 28 (2.63%) of all hospitalized pregnant women had died. Of the 1.065 patients, 783 (73.5%) were hospitalized before the Delta wave and the maternal mortality rate was 1.28% (10/783), 243 (22.8%) were hospitalized during the Delta wave and the maternal mortality rate was 7% (17/243) [relative risk (RR)=5.478, 95% confidence interval (CI) (2.54-11.8), z=4.342, p

Özet

Amaç: Delta ve Omikron dalgaları ile ilişkili olarak koronavirüs hastalığı-2019 (COVID-19) ile ilişkili anne ölümlerini sunmak ve akciğer ultrasonunun (AUS) hastalık şiddeti-mortalite tahminindeki rolünü araştırmaktır. Gereç ve Yöntemler: Bu retrospektif kohort çalışması, üçüncü basamak bir pandemi hastanesinin kadın hastalıkları ve doğum kliniğinde Mart 2020 ile Ocak 2022 tarihleri arasında yapılmıştır. Hastanede yatan COVID-19 tanılı gebeler ve anne ölümü olguları Delta ve Omikron dalgaları ile ilişkili olarak incelenmiştir. Hastanede yatan hastaların AUS skorları ile anne ölümleri arasındaki ilişki araştırılmıştır Bulgular: Bin altmış beş hamile kadın COVID-19 enfeksiyonu nedeniyle hastaneye yatırıldı. Bu hastaların 51’inde (%4,79) kritik hastalığa, 96’sında (%9,01) ağır bir hastalık mevcuttu, 62’si (%5,82) yoğun bakıma yatırıldı ve hastanede yatan tüm gebe hastaların 28’inde (%2,63) ölüm gerçekleşti. Delta dalgası öncesinde 783 (%73,5) hasta hastaneye yatırıldı, anne ölüm oranı %1,28 (10/783), Delta dalgası sırasında 243 (%22,8) COVID-19 hasta hastaneye yatırıldı ve anne ölüm oranı %7’di (17/243) [göreceli risk (RR)=5,478, %95 güven aralığı (GA) (2,54-11,8), z=4,342, p

🔖

Cite This Article

YASSA, M., ÇAVUŞOĞLU, G., TUĞ, N., YAVUZ, E., BUDAK, D., TEKİN, A. B., GÜNKAYA, O. S., İLTER, P. B., ÖNDEN, B., USTA, C., TAYMUR, B. D. (2022). COVID-19 related maternal mortality cases in associated with Delta and Omicron waves and the role of lung ultrasound. Turkish Journal of Obstetrics and Gynecology, Cilt: 19 - Sayı: 2, 88–97. https://ajindex.com/articles/612870

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Yap M, Debenham L, Kew T, Chatterjee SR, Allotey J, Stallings E, et al. Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: A living systematic review protocol. BMJ Open 2020;10:e041868
  2. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1641-7
  3. Gajbhiye RK, Sawant MS, Kuppusamy P, Surve S, Pasi A, Prusty RK, et al. Differential impact of COVID-19 in pregnant women from high- income countries and low- to middle-income countries: A systematic review and meta-analysis. Int J Gynecol Obstet 2021;155:48-56
  4. Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A, et al. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol 2020;223:911.e1-911.e14. 5.
  5. Siqueira TS, Souza EKG, Martins-Filho PR, Silva JRS, Gurgel RQ, MTropMed LEC, et al. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: A nationwide population- based cohort study. J Travel Med 2022:taab199
  6. Aslam J, Masroor M, Mehmood Q-U-A, Arshad M, Jabeen S, Mushtaq MA. Maternal Mortality with SARS-COV-2 during its 4th Wave in Pakistan: The Vaccine Paradox and Pregnancy. J Coll Physicians Surg Pak 2022;32:119-21
  7. Torres-Torres J, Martinez-Portilla RJ, Espino-y-Sosa S, Estrada-Gutierrez G, Solis-Paredes JM, Villafan-Bernal JR, et al. Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico. Ultrasound Obstet Gynecol 2022;59:76-82
  8. Diagnostic testing for SARS-CoV-2. WHO, Interim guidance 2020:20
  9. Mahajan N, Kesarwani S, Salunke C, Kumbhar P, Yenkure P, Shaikh J, et al. Clinical presentation, pregnancy complications and maternal outcomes of SARS-CoV-2 infection in pregnant women during the third wave of COVID-19 in Mumbai, India. Int J Gynaecol Obstet 2021;153:176-9
  10. Engjom H, van den Akker T, Aabakke A, Ayras O, Bloemenkamp K, Donati S, et al. Severe COVID-19 in pregnancy is almost exclusively limited to un